CA
PBH icon

Crewe Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Crewe Advisors’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-149
Closed -$8.83K – 1183
2026
Q1 		$8.83K Sell
149
-23
-13% -$1.49K ﹤0.01% 670
2025
Q4 		$10.6K Buy
172
+23
+15% +$1.41K ﹤0.01% 613
2025
Q3 		$9.3K Buy
+149
New +$10.4K ﹤0.01% 648
2024
Q3 		– Sell
-231
Closed -$15.9K – 919
2024
Q2 		$15.9K Buy
231
+174
+305% +$11.8K ﹤0.01% 595
2024
Q1 		$4.14K Buy
+57
New +$3.81K ﹤0.01% 768
2020
Q4 		– Sell
-147
Closed -$5K – 595
2020
Q3 		$5K Buy
+147
New +$5.47K ﹤0.01% 360

Other funds holding PBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Crewe Advisors's PBH Position: Q2 2026 in Review

Crewe Advisors sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 149 shares — an estimated $8.83K sold.

Crewe Advisors first reported a position in PBH in Q3 2020 and held it in 6 quarters. The position peaked at $15.9K in Q2 2024. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Crewe Advisors reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
  • Crewe Advisors sold 149 Prestige Consumer Healthcare shares in Q2 2026, an estimated $8.83K.
  • Crewe Advisors first reported a position in Prestige Consumer Healthcare in Q3 2020 and held it in 6 quarters.
  • Crewe Advisors's Prestige Consumer Healthcare position peaked at $15.9K in Q2 2024.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.